ADMP News Adamis Pharmaceuticl 7.07 $ADMP Explo

ADMP News Adamis Pharmaceuticl 7.07 $ADMP

ExploreLearning Reflex Raises Test Scores for Struggling Students
GlobeNewswire - Wed Feb 18, 8:09AM CST
ExploreLearning, a member of Cambium Learning Group, Inc. (Nasdaq:ABCD), announced the findings of a new two-year research study showing that struggling students who used their award-winning math fact fluency program, Reflex, saw substantial gains on a widely used, nationally normed mathematics assessment.
ABCD: 2.74 (+0.01)

Kurzweil 1000 Version 14 Improves Learning Experience for Blind and Visually Impaired Users
GlobeNewswire - Tue Feb 03, 7:00AM CST
Kurzweil Education(TM), Inc., a division of Cambium Learning(R) Group, Inc. (Nasdaq:ABCD), today announced the availability of Kurzweil 1000(TM) Version 14, the latest version of its award-winning text-to-speech software that makes printed or electronic text readily available to people who are blind or visually impaired.
ABCD: 2.74 (+0.01)

Learning A-Z Launches New Referral Program
GlobeNewswire - Thu Jan 15, 7:00AM CST
Learning A-Z, an online provider of PreK-6 education solutions and part of Cambium Learning Group, Inc., announced today the launch of its newly formed referral program.
ABCD: 2.74 (+0.01)

Factors Driving Markets: New Outlook on Cambium Learning Group, Canterbury Park, Capella Education, Career Education and CareTrust
PR Newswire - Fri Dec 26, 7:10AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Cambium Learning Group (NASDAQ: ABCD), Canterbury Park (NASDAQ: CPHC), Capella Education (NASDAQ: CPLA), Career Education (NASDAQ: CECO), and CareTrust (NASDAQ: CTRE). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
CTRE: 13.41 (-0.16), CPHC: 10.50 (+0.21), CPLA: 65.40 (+0.09), ABCD: 2.74 (+0.01), CECO: 6.00 (+0.87)

Cambium Learning Group Earns Reader's Choice Top 100 Distinction
PR Newswire - Fri Dec 19, 10:43AM CST
Cambium Learning® Group, Inc. [NASDAQ: ABCD], the educational solutions and services company that leverages engaging, innovative technology to help all students reach their full potential, announced today that products innovated by two of its business units--ExploreLearning® and Voyager Sopris Learning(TM)-- were selected to be among District Administration magazine's 2014 Reader's Choice Top 100 Products.
ABCD: 2.74 (+0.01)

Learning A-Z Announces New Headsprout Educator Grant Program
PR Newswire - Mon Dec 15, 4:00AM CST
Learning A-Z(TM), a PreK-6 educational resource company and part of Cambium Learning® Group, Inc. (NASDAQ: ABCD), announced today the launch of the newly created Headsprout® Educator Grant Program.
ABCD: 2.74 (+0.01)

Cambium Learning Group Technology Solutions Earn 2014 Awards of Excellence from Tech & Learning Magazine
PR Newswire - Thu Dec 04, 4:00AM CST
Cambium Learning® Group, Inc. (NASDAQ: ABCD), the educational solutions and services company that leverages engaging, innovative technology to help all students reach their full potential, announced today that three of its business units -- ExploreLearning®, Kurzweil Education(TM), and Learning A-Z(TM) -- were among the winners of the 32nd Annual Tech & Learning Awards of Excellence for Best Upgraded Product.
ABCD: 2.74 (+0.01)

Kurzweil Education Announces Pilot Program for Kurzweil 3000-firefly in Jordanian Schools
PR Newswire Europe - Wed Nov 26, 2:22PM CST
Kurzweil Education(TM), a division of Cambium Learning((R)) Group, Inc. , announced today that Sensotec nv/sa, Kurzweil Education's development and localization partner based in Belgium, and the Jordan Education Initiative (JEI), one of Her Majesty Queen Rania Al-Abdullah's not-for-profit organizations in Amman, Jordan, have signed a Memorandum of Understanding to pilot Kurzweil 3000((R))-firefly((R)) in four schools.
ABCD: 2.74 (+0.01)

Cambium Learning Group: Valued Education In A Deep Value Stock
David Waldron - at Seeking Alpha - Wed Nov 19, 7:24AM CST

ABCD: 2.74 (+0.01)

Cambium Learning EPS of $0.02
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 5:19PM CST

ABCD: 2.74 (+0.01)

Cambium Learning Group Announces Third Quarter Earnings
PR Newswire - Thu Nov 06, 4:03PM CST
Cambium Learning® Group, Inc. (NASDAQ: ABCD, the "Company" , a leading educational solutions and services company committed to helping all students reach their full potential by providing evidence-based solutions and expert professional services, announced today its financial results for the third quarter of 2014.
ABCD: 2.74 (+0.01)

Cambium Learning Group, Inc. Announces Date for 2014 Third-Quarter Earnings Release
PR Newswire - Wed Oct 29, 3:48PM CDT
Cambium Learning® Group, Inc. (NASDAQ: ABCD), (the "Company" , a leading educational solutions and services company committed to helping all students reach their full potential by providing evidence-based solutions and expert professional services, today announced that it will release its 2014 third-quarter financial results on Thursday, November 6, 2014. The release will be based on unaudited results through September 30, 2014.
ABCD: 2.74 (+0.01)

John Campbell of Cambium Learning Group has been selected by ExecRank as a Top Chief Executive Officer for 2014
PR Newswire - Mon Oct 13, 4:00AM CDT
Cambium Learning® Group, Inc. (NASDAQ: ABCD) is pleased to announce that John Campbell has been recognized by ExecRank as a Top Chief Executive Officer at a Micro-Cap Company for 2014. These rankings are based on statistical and algorithmic analysis of executive and company performance and are the result of more than three years of research and feedback from evaluation committees and top Chief Executives.
ABCD: 2.74 (+0.01)

Learning A-Z Launches ReadyTest A-Z
PR Newswire - Thu Oct 09, 4:00AM CDT
Learning A-Z(TM), a PreK-6 educational resource company and part of Cambium Learning® Group, Inc. (NASDAQ: ABCD), has launched a new website, ReadyTest A-Z.
ABCD: 2.74 (+0.01)

Cambium Learning Group Wins Six 2014 EDDIE Awards
PR Newswire - Fri Oct 03, 4:00AM CDT
Cambium Learning® Group, Inc. (NASDAQ: ABCD) announced today that it won six 2014 Education Software Review (EDDIE) Awards: two by ExploreLearning®, one by Kurzweil Education(TM), and three by Learning A-Z(TM).
ABCD: 2.74 (+0.01)

Voyager Sopris Learning's We Can Early Learning Curriculum Approved by Illinois Governor's Office of Early Childhood Development
PR Newswire - Wed Sep 17, 4:00AM CDT
Voyager Sopris Learning(TM) announced today that the State of Illinois Governor's Office of Early Childhood Development has recognized the We Can Early Learning Curriculum as an approved curriculum for PreK and Early Learning programs.
ABCD: 2.74 (+0.01)

Voyager Sopris Learning's Fall Webinar Series Brings Educators in Contact with World-Renowned Authors, Educators, and Researchers for Fifth Year
PR Newswire - Fri Sep 12, 4:00AM CDT
Voyager Sopris Learning(TM) announced today that its complimentary webinar series is open for registration. The fall 2014 webinars focus on ways to improve student outcomes--both academically and socially--and prepare students for college and career.
ABCD: 2.74 (+0.01)

Learning A-Z's Reading Solution Voted a Top Resource for Teachers and Students in Independent Survey
PR Newswire - Tue Sep 09, 4:00AM CDT
Learning A-Z, a PreK-6 educational resource company and business unit of Cambium Learning® Group, Inc. (NASDAQ: ABCD), announced today that its award-winning Reading Solution is the top-ranked online reading resource for teachers and students in an independent survey.
ABCD: 2.74 (+0.01)

ABM Industries' (ABM) CEO Henrik Slipsager Discusses on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Mar 04, 1:24PM CST

ABM: 29.37 (-1.74)

Do-It-Yourself All Sector Dividend Aristocrat Portfolio
Aaron Barton - at Seeking Alpha - Wed Mar 04, 12:45PM CST

BDX: 148.36 (+2.10), MDT: 78.19 (+0.16), ED: 61.87 (-0.30), KMB: 108.37 (-1.89), SYY: 38.81 (-0.09), WMT: 82.58 (-0.79), HP: 66.63 (-0.70), GRC: 28.30 (-0.67), GWW: 236.00 (-5.29), UVV: 48.10 (+0.28), THFF: 33.75 (+0.03), T: 34.00 (-0.41), JNJ: 101.65 (-0.69), NWN: 45.86 (-0.71), EGN: 66.22 (+1.02), TGT: 77.72 (-0.28), CWT: 24.54 (+0.24), WEYS: 28.43 (-0.40), ORI: 14.73 (-0.40), NFG: 62.30 (-0.62), DBD: 35.35 (-0.12), KO: 42.50 (-0.45), STR: 23.04 (-0.19), ABT: 47.01 (-0.08), HCP: 41.78 (-0.44), ATO: 53.12 (-0.17), SCL: 40.68 (-0.20), MSEX: 22.25 (-0.53), ADP: 86.57 (-2.13), ADM: 47.08 (-0.44), MCD: 100.25 (+0.51), SJW: 31.82 (-0.33), DOV: 71.63 (-0.50), RAVN: 20.64 (-0.39), CVX: 105.16 (unch), NC: 56.65 (-0.25), AFL: 62.35 (+0.07), BRC: 26.91 (-0.33), ABM: 29.37 (-1.74)

ABM Marginally Beats on Q1 Earnings with Record Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 9:10AM CST
ABM Industries Incorporated (ABM) reported first-quarter fiscal 2015 adjusted earnings of 38 cents per share, which marginally beat the Zacks Consensus Estimate by a penny.
HURN: 66.86 (-0.21), CEB: 79.86 (-0.96), CRAI: 31.53 (+0.04), ABM: 29.37 (-1.74)

ABM Industries beats by $0.04, revenue in-line
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 4:02PM CST

ABM: 29.37 (-1.74)

ABM Scales New 52-Week High on Sustained Organic Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 11:10AM CST
Shares of leading provider of facility solutions ABM Industries Incorporated (ABM) scaled a new 52-week high of $31.42 during yesterday's trading session.
HURN: 66.86 (-0.21), CEB: 79.86 (-0.96), CRAI: 31.53 (+0.04), ABM: 29.37 (-1.74)

DXP Q4 Earnings Miss, Sales Beat on Acquisition Benefits - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 8:40AM CST
Premium industrial equipment company, DXP Enterprises, Inc. (DXPE) reported moderate results for fourth-quarter 2014.
BAH: 30.04 (-0.22), KAI: 46.05 (-0.29), DXPE: 46.00 (-1.30), ABM: 29.37 (-1.74)

Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 4:35PM CST

AMBA: 67.49 (+4.44), BV: 6.41 (-2.67), AMRN: 1.69 (+0.15), AVAV: 25.65 (-2.41), BOBE: 46.36 (-13.28), TNET: 33.93 (-3.95), CECO: 6.00 (+0.87), VEEV: 25.72 (-6.97), REGI: 9.56 (+0.42), TIVO: 11.56 (+0.31), EGL: 35.47 (-2.65), ZLTQ: 32.05 (-0.61), LRE: 8.09 (-0.07), GERN: 2.81 (-0.15), ASNA: 13.38 (+0.15), CDXS: 3.90 (+0.12), SWHC: 14.34 (+1.29), ABM: 29.37 (-1.74)

ABM Industries Up 13.0% Since SmarTrend Uptrend Call (ABM)
Comtex SmarTrend(R) - Thu Feb 19, 9:32AM CST
SmarTrend identified an Uptrend for ABM Industries (NYSE:ABM) on October 29th, 2014 at $27.14. In approximately 4 months, ABM Industries has returned 12.95% as of today's recent price of $30.65.
ABM: 29.37 (-1.74)

ABM to Present at Baird's 2015 Business Solutions Conference
GlobeNewswire - Tue Feb 17, 11:23AM CST
ABM (NYSE:ABM), a leading provider of facility solutions, today announced that Scott Salmirs, executive vice president, James Lusk, executive vice president, and David Farwell, senior vice president, will be presenting at the Baird Business Solutions Conference on Tuesday, February 24, 2015. The presentation will be held at The Pierre Hotel located in New York, New York and will begin at 3:35 p.m. ET.
ABM: 29.37 (-1.74)

The Hidden Risk Of High Dividend Growth Stocks
Kurtis Hemmerling - at Seeking Alpha - Mon Feb 16, 5:08AM CST

BDX: 148.36 (+2.10), ADP: 86.57 (-2.13), ADM: 47.08 (-0.44), ATO: 53.12 (-0.17), APD: 154.74 (-1.32), ABM: 29.37 (-1.74)

Can VASCO (VDSI) Keep its Earnings Streak Alive in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 10:00AM CST
VASCO Data Security International Inc. (VDSI) is set to report its fourth-quarter 2014 results before the opening bell on Feb 17.
VDSI: 23.29 (-0.42), KR: 69.65 (-0.33), ABM: 29.37 (-1.74), TV: 34.46 (-0.26)

ABM to Reduce West Boylston, MA Energy and Operating Costs by More Than $4.1 Million
GlobeNewswire - Thu Feb 12, 6:07PM CST
ABM (NYSE:ABM), a leading provider of facility solutions, announces that this month its ABM Building Solutions business will complete a multi-million dollar contract of extensive energy and facility improvements to government and school buildings throughout the Town of West Boylston in Massachusetts. ABM's Bundled Energy Solutions program guarantees that the project will save the Town of West Boylston at least $4.1 million in energy and operating costs over the next 15 years.
ABM: 29.37 (-1.74)

ABM Awarded Integrated Facility Solutions Contract by Harley-Davidson
GlobeNewswire - Tue Feb 10, 4:00PM CST
ABM (NYSE:ABM), a leading provider of facility solutions, has been awarded a multi-phased, integrated facility solutions contract by Harley-Davidson Motor Company.
ABM: 29.37 (-1.74)

5 Reasons To Take A Look At Telkonet
Joe Springer - Seeking Alpha - Mon Feb 02, 4:19PM CST
Telkonet (OTCQB: TKOI ) is an intelligent automation company that provides networked services for large commercial and residential buildings and facilities. Its services provide energy and operational savings as well as added value for its customers....
HON: 103.05 (-0.99), ENOC: 11.15 (-0.71), NMRX: 10.74 (-0.21), JCI: 50.70 (-0.75), CTRL: 12.54 (+0.23), ABM: 29.37 (-1.74)

Can Vulcan Materials (VMC) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 1:10PM CST
Vulcan Materials Company (VMC) is set to report fourth-quarter fiscal 2014 results on Feb 5, before the market opens.
TPH: 15.11 (+0.12), VMC: 84.60 (-0.17), SERV: 35.21 (+0.08), ABM: 29.37 (-1.74)

Can Jacobs (JEC) Deliver Yet Another Earnings Beat in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 27, 4:05PM CST
Jacobs Engineering Group Inc. (JEC) is scheduled to report first-quarter fiscal 2015 results after the opening bell on Jan 28, 2015.
JEC: 43.78 (-0.21), GPN: 92.01 (+0.01), WNS: 25.43 (-0.23), ABM: 29.37 (-1.74)

Is ABM Industries (ABM) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 7:52AM CST
ABM Industries in the Building-Maintenance and Services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective
ABM: 29.37 (-1.74)

ABM Industries Appoints New Chief Executive Officer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 13, 9:40AM CST
ABM Industries Incorporated (ABM), recently announced the appointment of Scott Salmirs as its Chief Executive Officer (CEO).
CBZ: 8.94 (-0.07), SERV: 35.21 (+0.08), ROL: 33.91 (-0.23), ABM: 29.37 (-1.74)

ABM appoints Scott Salmirs as CEO
M2 - Tue Jan 13, 3:59AM CST
ABM (NYSE:ABM), a provider of facility solutions, disclosed on Tuesday that its board of directors elected executive vice president (EVP) Scott Salmirs as successor to current president and chief executive officer (CEO) Henrik Slipsager, as of 31 March 2015.
ABM: 29.37 (-1.74)

ABM Names Industry Veteran Scott Salmirs as Next CEO
Business Wire - Mon Jan 12, 3:01PM CST
ABM (NYSE:ABM), a leading provider of facility solutions, today announced that its board of directors has named executive vice president Scott Salmirs to succeed current president and chief executive officer Henrik Slipsager, effective March 31, 2015. The board and Slipsager together determined that because of the company's recent strong performance, its depth of talent, and the completion of its reorganization and re-branding, it is the appropriate time to effect a leadership transition as a part of the board's succession planning.
ABM: 29.37 (-1.74)

Tinder's New Premium Service to Cost More for Users Over 30 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 2:14PM CST
IAC/InteractiveCorp (IACI) owned popular free mobile-dating app Tinder released its new premium service, Tinder Plus, in a bid to generate revenues.
ABTL: 14.52 (+0.69), PETS: 15.08 (-0.05), IACI: 68.46 (+0.04), TWTR: 47.57 (-0.14)

Alibaba Accused of Fake Orders to Pad Sales, Shares Bear the Brunt - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 1:13PM CST
Alibaba's (BABA) journey as a public company hasn't exactly been a smooth one.
ABTL: 14.52 (+0.69), PETS: 15.08 (-0.05), JD: 27.72 (+0.19), BABA: 85.49 (+3.91)

Amazon.com (AMZN) Now Shows the 'Ship to Cuba' Option - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 3:20PM CST
Amazon.com Inc (AMZN) seems to be laying the foundation to ship packages to Cuba.
AMZN: 382.72 (-1.89), ABTL: 14.52 (+0.69), PETS: 15.08 (-0.05), EVLV: 6.36 (-0.01)

Google's Android for Work: A Blessing for Enterprises? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 4:20PM CST
In an attempt to dig into the business class pockets, Google Inc. (GOOGL) has finally rolled out Android for Work.
ABTL: 14.52 (+0.69), PETS: 15.08 (-0.05), GOOGL: 578.33 (-0.46), AAPL: 128.54 (-0.82)

Google Inc (GOOGL) Updates Flight Shopping Features - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 3:20PM CST
Google Inc. (GOOGL) rolled out "Google Flights", the final version of its flight-shopping site, last week.
ABTL: 14.52 (+0.69), PETS: 15.08 (-0.05), EXPE: 89.87 (-1.15), GOOGL: 578.33 (-0.46)

Zacks Rank #1 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
CBRL: 149.57 (-2.19), AVA: 33.19 (-0.37), ABTL: 14.52 (+0.69), ESE: 39.05 (-0.22), BURL: 56.76 (+0.75)

Market Maker Surveillance Report. TTI, ABTL, AVEO, EYES, CLNE, XIN, Winning Stocks With Lowest Price Friction For Friday, February 27th 2015
M2 - Mon Mar 02, 5:29AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5214 companies with "abnormal" market making, 2975 companies with positive Friction Factors and 3319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. TETRA Technologies Inc (NYSE:TTI), Autobytel Inc (NASDAQ:ABTL), Aveo Pharmaceuticals Inc (NASDAQ:AVEO), VISION TWENTY-ONE INC (NASDAQ:EYES), Clean Energy Fuels Corp (NASDAQ:CLNE), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
EYES: 14.91 (+0.16), ABTL: 14.52 (+0.69), XIN: 3.25 (-0.07), AVEO: 1.54 (+0.39), TTI: 5.55 (-0.14), CLNE: 5.63 (-0.06)

Nasdaq stocks posting largest percentage increases
AP - Fri Feb 27, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
XENT: 25.06 (-0.82), EGLE: 9.82 (-0.22), MNST: 139.54 (-1.15), AIRM: 53.47 (+1.74), UNXL: 6.48 (-0.22), FLML: 15.84 (-0.06), ABTL: 14.52 (+0.69), AKRX: 51.19 (+1.86), PGTI: 11.28 (+0.33), HEES: 25.15 (+0.15), TORM: 6.40 (-0.20), CNCE: 14.55 (-0.18), ROVI: 21.73 (-1.11)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 11:55AM CST

EYES: 14.91 (+0.16), UNXL: 6.48 (-0.22), AIRM: 53.47 (+1.74), DGI: 34.94 (-0.24), TBIO: 1.76 (+0.06), VTAE: 11.09 (-0.06), ENOC: 11.15 (-0.71), BIOC: 3.39 (+0.01), TTI: 5.55 (-0.14), CLNE: 5.63 (-0.06), CALI: 1.19 (-0.09), RESN: 11.44 (+0.49), EGL: 35.47 (-2.65), CYCC: 1.10 (-0.32), ABTL: 14.52 (+0.69), TUBE: 13.19 (+0.88), XIN: 3.25 (-0.07), CAS: 3.40 (-0.19), TCPI: 2.82 (+0.11), WTW: 9.97 (-0.62)

Autobytel +21.7% on big Q4 EPS beat, strong 2015 guidance
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 11:31AM CST

ABTL: 14.52 (+0.69)

Google's Android is Finally Ready to go to Work! - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 11:20AM CST
It has been almost eight months since Google first announced its concept of Android for Work at its Google I/O conference.
ABTL: 14.52 (+0.69), GOOGL: 578.33 (-0.46), EVLV: 6.36 (-0.01), AAPL: 128.54 (-0.82)

Amazon Hits New 52-Week High due to Strong Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 10:40AM CST
Shares of Amazon.com Inc. (AMZN) touched a new 52-week high of $389.4 on Feb 26, eventually closing at $384.8.
AMZN: 382.72 (-1.89), ABTL: 14.52 (+0.69), PETS: 15.08 (-0.05), EVLV: 6.36 (-0.01)

Autobytel (ABTL) CEO Jeff Coats on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 10:00PM CST

ABTL: 14.52 (+0.69)

Autobytel posts 4Q profit
Automated Insights - Thu Feb 26, 7:07PM CST
IRVINE, Calif. (AP) _ Autobytel Inc. (ABTL) on Thursday reported fourth-quarter net income of $1.1 million.
ABTL: 14.52 (+0.69)

Priceline (PCLN) Prices EUR 1B Unsecured Senior Notes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 26, 4:24PM CST
Priceline.com (PCLN) recently announced the pricing of Senior Unsecured Notes aggregating EUR1 billion, carrying a coupon rate of 1.8% due in 2027 in an underwritten public offering.
ABTL: 14.52 (+0.69), PETS: 15.08 (-0.05), EVLV: 6.36 (-0.01), PCLN: 1,225.67 (-16.36)

Autobytel beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 3:26PM CST

ABTL: 14.52 (+0.69)

Inaugural Books from Amazon Kindle Scout Next Week - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 4:36PM CST
In October last year, Amazon.com Inc. (AMZN) introduced a crowd-sourced publishing platform, Kindle Scout, that allows readers to vote for those unpublished authors that they would like in their devices. The company is now ready to release the first batch of titles on Mar 3.
AMZN: 382.72 (-1.89), ABTL: 14.52 (+0.69), PETS: 15.08 (-0.05), EVLV: 6.36 (-0.01)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 4:35PM CST

HLF: 31.45 (+0.21), MNST: 139.54 (-1.15), NOG: 7.79 (unch), MAIN: 31.12 (-0.11), MVNR: 17.29 (+0.24), EVHC: 37.51 (+1.31), RP: 19.78 (+0.02), ENV: 56.43 (+1.26), BCEI: 27.56 (+0.14), CLNE: 5.63 (-0.06), MITT: 19.10 (+0.23), KBR: 15.78 (+0.19), NVAX: 8.83 (+0.26), PKT: 9.12 (-0.12), KND: 22.08 (-0.01), CSU: 25.28 (-0.06), OLED: 36.58 (+0.60), IM: 24.88 (-0.21), DGI: 34.94 (-0.24), AHT: 10.32 (-0.10), LYV: 26.15 (-0.04), ECOL: 51.75 (+2.85), PEGA: 20.33 (-0.32), PODD: 30.96 (-0.41), CROX: 11.52 (+0.22), AVD: 10.44 (-0.42), AL: 38.17 (+0.13), RBA: 25.24 (+0.39), ADSK: 62.52 (-0.18), ECPG: 39.16 (-0.50), AIRM: 53.47 (+1.74), ARUN: 24.40 (-0.01), ENOC: 11.15 (-0.71), AEGR: 28.02 (+0.56), MDRX: 12.32 (-0.03), RMTI: 10.40 (+0.12), HPTX: 29.73 (-0.05), PSIX: 57.00 (+0.99), ABTL: 14.52 (+0.69), PFMT: 4.15 (-0.24), R: 93.65 (-0.03), CERS: 4.46 (+0.02), EVC: 6.58 (-0.18), IMMR: 8.32 (+0.23), CUBE: 22.93 (-0.49), BLOX: 24.05 (-0.13), OUT: 30.27 (+0.03), OVTI: 27.07 (+0.26), MTZ: 20.98 (-0.36), APEI: 30.70 (+0.17), MENT: 23.32 (-0.47), BIO: 132.91 (-0.24), JCP: 7.88 (unch), PE: 14.49 (-0.03), NMBL: 25.49 (-0.23), GPS: 42.03 (+0.05), ROST: 105.12 (-0.42)

Is Amazon Considering Distribution Center in Shakopee? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 25, 4:13PM CST
Reportedly, Amazon.com Inc. (AMZN), the world's largest online retailer, is in negotiations to purchase a 66-acre plot in Shakopee's Shenandoah Business Park.
AMZN: 382.72 (-1.89), ABTL: 14.52 (+0.69), PETS: 15.08 (-0.05), EVLV: 6.36 (-0.01)

Acorn Energy Announces Receipt of Nasdaq Notice of Bid Price Deficiency
PR Newswire - Fri Jan 16, 3:48PM CST
Acorn Energy, Inc. (NASDAQ: ACFN), today announced that on January 13, 2015, it received a letter from the Nasdaq Listings Qualification Staff stating that the Company is not in compliance with the continued listing requirements of The Nasdaq Global Market because the bid price of the Company's common stock has closed below the minimum $1.00 per share requirement of Listing Rule 5450(a)(1) for 30 consecutive business days.
ACFN: 0.71 (+0.03)

Acorn Energy (ACFN) Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 12:30PM CST

ACFN: 0.71 (+0.03)

Acorn Energy misses by $0.03, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:16PM CST

ACFN: 0.71 (+0.03)

Acorn Energy Announces Third Quarter and Nine Month 2014 Results
PR Newswire - Wed Nov 12, 3:09PM CST
Acorn Energy, Inc. (NASDAQ: ACFN), today announced the results for the third quarter and nine-month periods ended September 30, 2014.
ACFN: 0.71 (+0.03)

Acorn Energy to Host 2014 Third Quarter Conference Call on Thursday, November 13, 2014 at 11:00 am ET
PR Newswire - Fri Nov 07, 12:35PM CST
Acorn Energy, Inc. (NASDAQ: ACFN) today announced that John A. Moore, President & CEO of Acorn Energy, will host an investor call on Thursday, November 13, 2014 at 11am ET to discuss its third quarter 2014 results and developments. The Company will release financial results for the third quarter the afternoon of Wednesday November 12th, after the market closes.
ACFN: 0.71 (+0.03)

US Seismic Systems® Inc, an Acorn Energy Company, Receives an Order for its Oilfield Fiber-Optic Sensor System
PR Newswire - Thu Nov 06, 12:07PM CST
US Seismic Systems, Inc., an Acorn Energy, Inc. (NASDAQ: ACFN) company announced today that it has secured an order of strategic importance for its Optiphone HD(TM) Ultra-High Sensitivity fiber-optic based sensor system. Working with one of its partners, a major oilfield services company, USSI will supply two arrays under this order.
ACFN: 0.71 (+0.03)

Acorn Energy Raises $4.5 Million In Private Placement of Unregistered Shares of Common Stock and Warrants
PR Newswire - Fri Oct 31, 1:45PM CDT
Acorn Energy, Inc. (NASDAQ: ACFN) (the "Company" or "Acorn" today announced that it has entered into definitive agreements with accredited investors in connection with a private placement of unregistered shares common stock and warrants to purchase common stock. Upon the closing of this financing, Acorn will receive gross proceeds of approximately $4.5 million resulting from the issuance and sale of 4,285,714 unregistered shares of common stock at a price per share of $1.05 and warrants to purchase up to 2,142,857 shares of common stock at an exercise price of $1.30 per share. The warrants are non-exercisable for six months after the closing of the financing and have a term of 5.5 years.
ACFN: 0.71 (+0.03)

Former Chairman And CEO Of DuPont To Join Acorn Energy As Director
PR Newswire - Fri Oct 31, 12:14PM CDT
Acorn Energy, Inc. (NASDAQ: ACFN), an energy technology holding company, announced today that Edgar S. Woolard, Jr. has accepted the Board's invitation to serve as a Director. Mr. Woolard will fill the vacancy created by the recent resignation of Andy Sassine.
ACFN: 0.71 (+0.03)

US Seismic Systems® Completes Fracture Monitoring Project in Texas
PR Newswire - Mon Oct 27, 9:00AM CDT
US Seismic Systems, Inc., an Acorn Energy, Inc. company (NASDAQ: ACFN) announced today that in partnership with a European oil and gas multinational and a US exploration and production company it has successfully completed a two week long hydraulic fracture monitoring project. The project which took place in Texas was at the behest of the European multinational who wanted to assess the capabilities of the USSI technology during an actual frac job.
ACFN: 0.71 (+0.03)

US Seismic Systems, Inc. Technology Validated by Two Peer-Review Papers
PR Newswire - Thu Oct 16, 1:17PM CDT
Acorn Energy, Inc. (NASDAQ: ACFN) today announced that two recently published peer-reviewed papers indicate that US Seismic System's Optiphone HD(TM) 3C fiber-optic sensor system proved superior to existing downhole well monitoring technology, as well as a new-technology competitor, in tests this summer. One test was conducted by ConocoPhillips Company near Houston, in the Texas Eagle Ford shale formation, and the other test was performed by SR2020, in Devine, Texas.
ACFN: 0.71 (+0.03)

Hot Stock: Acorn Energy, Shares Gain 7.1% (ACFN)
Comtex SmarTrend(R) - Tue Sep 23, 11:38AM CDT
Acorn Energy (NASDAQ:ACFN) is one of today's best performing low-priced stocks, up 7.1% to $1.80 on 1.0x average daily volume. Thus far today, Acorn Energy has traded 257,000 shares, vs. average volume of 245,000 shares per day. The stock has outperformed the Dow (7.1% to the Dow's -0.3%) and outperformed the S&P 500 (7.1% to the S&P's -0.3%) during today's trading.
ACFN: 0.71 (+0.03)

Navy Orders DSIT's AquaShield(TM) Diver Detection Sonar
PR Newswire - Tue Sep 23, 8:30AM CDT
DSIT Solutions Ltd., a subsidiary of Acorn Energy, Inc. (NASDAQ: ACFN), announced today that a leading Mediterranean Navy has placed an order for its AquaShield(TM) Diver Detection Sonar (DDS) system. The system is expected to guard the underwater perimeter of a strategic coastal asset.
ACFN: 0.71 (+0.03)

Acorn Energy to Host Annual Stockholder Meeting September 23, 2014 in Delaware
PR Newswire - Fri Sep 19, 5:53PM CDT
Acorn Energy, Inc. (NASDAQ: ACFN) reminds stockholders that they are invited to attend the annual stockholder meeting on Tuesday, September 23, 2014 at noon EDT at Westin Hotel, 818 Shipyard Drive on the Riverfront in Wilmington, DE. Lunch will be served. Please RSVP to acorn@acornenergy.com.
ACFN: 0.71 (+0.03)

DSIT Receives Another Nuclear Power Plant Order for its Underwater Security System
PR Newswire - Mon Sep 08, 8:30AM CDT
DSIT Solutions Ltd., a subsidiary of Acorn Energy, Inc. (NASDAQ: ACFN), announced today that it has received another order for its Underwater Security System for the protection of a Nuclear Power Plant. The Underwater Security System ordered is based on a special version of the company's best-selling AquaShield(TM) Diver Detection Sonar. This special version is specifically tailored to provide superior performance against any type of intruder approaching the nuclear power plant's highly reverberant water intake. The threats that the system is designed to counter include scuba and combat divers, divers using Diver Propulsion Vehicles (DPV) and Unmanned Underwater Vehicles (UUV).
ACFN: 0.71 (+0.03)

DSIT receives order for Underwater Security System from nuclear power facility in Europe
M2 - Wed Aug 27, 3:01AM CDT
DSIT Solutions Ltd, a subsidiary of a holding company Acorn Energy Inc (NASDAQ:ACFN) that develops and produces sonar applications and security systems, revealed on Tuesday that it received an order for its Underwater Security System, from a European Nuclear Power facility.
ACFN: 0.71 (+0.03)

DSIT to Supply an Underwater Security System to a European Nuclear Power Facility
PR Newswire Europe - Tue Aug 26, 9:01AM CDT
DSIT Solutions Ltd., a subsidiary of Acorn Energy, Inc. , announced today that it has received an order for its Underwater Security System to protect a European Nuclear Power facility. The system is expected to be installed on site before the end of 2014.
ACFN: 0.71 (+0.03)

Acorn Energy Announces Second Quarter and Six Month 2014 Results
PR Newswire - Mon Aug 11, 3:01PM CDT
Acorn Energy, Inc. (NASDAQ: ACFN), today announced the results for the second quarter and six-month periods ended June 30, 2014.
ACFN: 0.71 (+0.03)

Acorn Energy to Host 2014 Second Quarter Conference Call on Tuesday, August 12, 2014 at 11:00 am EDT
PR Newswire - Mon Aug 04, 5:16PM CDT
Acorn Energy, Inc. (NASDAQ: ACFN) today announced that John A. Moore, President & CEO of Acorn Energy, will host an investor call on Tuesday, August 12, 2014 at 11am EDT to discuss its first quarter 2014 results and developments. The Company will release financial results for the second quarter the afternoon of Monday, August 11th, after the market closes.
ACFN: 0.71 (+0.03)

Acorn Energy's US Seismic Systems® Adds Seismic Industry Veteran President & CEO
PR Newswire - Tue Jul 29, 3:01PM CDT
US Seismic Systems®, Inc. (USSI®), a subsidiary of Acorn Energy, Inc. (ACFN), is pleased to announce that Mark A. Bashforth has been named the new President and CEO of USSI.
ACFN: 0.71 (+0.03)

Acadia Healthcare Acquires Quality Addiction Management
Business Wire - Mon Mar 02, 6:00AM CST
--Transaction Expected to be Accretive to 2015 Earnings by Approximately $0.03 to $0.04
ACHC: 65.59 (+0.20)

Insider Trading Alert - SLH, ESNT And ACHC Traded By Insiders
at The Street - Mon Feb 23, 12:45PM CST
Stocks with insider trader activity include SLH, ESNT and ACHC
ACHC: 65.59 (+0.20), SLH: 55.38 (-0.52), ESNT: 23.90 (+0.49)

Sector Rankings Stay Neutral With Few Bullish Catalysts On Horizon
Scott Martindale - at Seeking Alpha - Wed Feb 18, 12:49AM CST
Stocks are hitting new highs across the board, even though earnings reports have been somewhat disappointing. Actually, to be more precise, Q4 results have been pretty good, but it is forward guidance that has been cautious and/or cloudy as sales...
IYK: 107.02 (-0.74), ACHC: 65.59 (+0.20), IYJ: 109.53 (-0.81), BX: 38.61 (+0.76), IYH: 153.65 (+0.60), IYM: 85.83 (-0.31), IYC: 144.92 (-0.81), AMP: 133.62 (-0.85), IYF: 89.58 (-0.57), IYE: 44.43 (-0.09), KBWI: 69.62 (+0.36), IHF: 128.34 (+1.42), IYZ: 30.73 (-0.16), SPY: 210.23 (-0.89), MRVL: 16.21 (+0.21), IDU: 111.39 (-0.79), FONE: 40.65 (-0.07), MD: 71.11 (+0.54), AVGO: 129.40 (+1.18), IYW: 108.49 (-0.41)

ACADIA HEALTHCARE
at Investor's Business Daily - Wed Feb 11, 6:00PM CST
ACADIA HEALTHCARE (ACHC) issued weak Q1 EPS guidance, but the midpoint of its $2.03-$2.10 '15 EPS range is above analysts' $2.05. Q4 EPS jumped 59%, in line. Revenue rose 55%, missing. Shares fell 2.7% to 62.99.
ACHC: 65.59 (+0.20)

Acadia Healthcare (ACHC) Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 11:10AM CST

ACHC: 65.59 (+0.20)

Acadia Healthcare Posts In-Line Q4 Earnings, Revenue Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:54AM CST
Acadia Healthcare Company (ACHC) reported fourth-quarter 2014 adjusted earnings (EPS) of 46 cents per share, which surged an impressive 58.6% year over year.
ACHC: 65.59 (+0.20), ABMD: 61.24 (+1.09), INGN: 33.81 (+0.47), SURG: 4.63 (+0.02)

Regional Banks Are The Way To Go - Cramer's Lightning Round (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 5:05AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 11. Bullish Calls: HomeAway (NASDAQ: AWAY ): "The stock market is saying it is overvalued but I think don't give up on CEO Brian." ...
ACHC: 65.59 (+0.20), KMI: 41.04 (-0.05), CY: 15.20 (+0.04), AWAY: 31.01 (-0.79), BBT: 37.81 (-0.36), PWR: 28.60 (-0.10), AMGN: 159.19 (+0.63), BA: 154.35 (-1.22), AFFX: 11.83 (+0.09), TWX: 83.08 (-0.08), CELG: 119.57 (+1.10), VIA: 71.20 (-0.74), ETP: 58.25 (-0.76), FSL: 40.36 (-0.14), VIAB: 70.86 (-0.62), REGN: 413.04 (+0.53)

'Mad Money' Lightning Round: Buy, Buy, Buy Boeing Below $140
at The Street - Thu Feb 12, 5:00AM CST
Cramer says don't give up on HomeAway, Quanta Services is too risk but Acadia Healthcare is terrific.
ACHC: 65.59 (+0.20), KMI: 41.04 (-0.05), CY: 15.20 (+0.04), SWKS: 90.15 (+1.41), AWAY: 31.01 (-0.79), BBT: 37.81 (-0.36), PWR: 28.60 (-0.10), AMGN: 159.19 (+0.63), KEY: 13.90 (-0.10), BA: 154.35 (-1.22), AFFX: 11.83 (+0.09), TWX: 83.08 (-0.08), CELG: 119.57 (+1.10), ETP: 58.25 (-0.76), STI: 40.96 (-0.46), FSL: 40.36 (-0.14), VIAB: 70.86 (-0.62), REGN: 413.04 (+0.53)

Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.04 (-0.05), ACHC: 65.59 (+0.20), FLEX: 11.94 (+0.02), GE: 25.66 (-0.20), BBT: 37.81 (-0.36), AWAY: 31.01 (-0.79), XOM: 87.18 (-0.44), KEY: 13.90 (-0.10), INTC: 34.12 (+0.02), AFFX: 11.83 (+0.09), TWX: 83.08 (-0.08), PEP: 97.36 (-1.04), AEP: 56.58 (-0.15), ETP: 58.25 (-0.76), CMG: 664.16 (-4.27), QLYS: 47.48 (+0.21), GOOGL: 578.33 (-0.46), MSFT: 43.06 (-0.22), HSIC: 140.87 (+0.10), AAPL: 128.54 (-0.82), REGN: 413.04 (+0.53), CSCO: 29.33 (-0.21), CY: 15.20 (+0.04), SWKS: 90.15 (+1.41), PWR: 28.60 (-0.10), FB: 80.89 (+1.29), PFE: 34.64 (+0.08), HAL: 43.07 (-0.04), AMGN: 159.19 (+0.63), BAC: 15.84 (-0.20), BMY: 65.67 (+3.75), BA: 154.35 (-1.22), HPQ: 34.19 (-0.38), RAD: 8.05 (-0.05), CELG: 119.57 (+1.10), ZTS: 46.23 (-0.31), UA: 75.51 (-0.93), AA: 14.59 (-0.59), GILD: 103.06 (+0.27), STI: 40.96 (-0.46), GM: 37.57 (-0.23), AGIO: 107.12 (+1.46), CRL: 76.61 (+0.99), FSL: 40.36 (-0.14), VIAB: 70.86 (-0.62), CL: 70.68 (unch)

Acadia Healthcare EPS in-line, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 3:01PM CST

ACHC: 65.59 (+0.20)

Acadia Healthcare Reports Growth of 58.6% in Fourth Quarter Adjusted EPS to $0.46 and 55.2% in Revenue to $294.9 Million, Including 12.2% Growth in Same Facility Revenue
Business Wire - Wed Feb 11, 3:00PM CST
--Establishes Guidance for 2015 Adjusted Earnings per Diluted Share in Range of $2.03 to $2.10
ACHC: 65.59 (+0.20)

Stocks Mixed In Quiet Session; Pacira, Zoetis Ramp Higher
at Investor's Business Daily - Wed Feb 11, 12:26PM CST
Stocks were quietly mixed in early afternoon trading Wednesday as Greece started talks with eurozone finance ministers about a debt compromise. The Nasdaq picked up 0.2% while the S&P 500 and the Dow Jones industrial average lost 0.3% each. NYSE and...
ACHC: 65.59 (+0.20), ZTS: 46.23 (-0.31), TSLA: 202.43 (+2.87), FSLR: 61.20 (+0.51), AAPL: 128.54 (-0.82), PCRX: 95.39 (+1.45)

Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 4:35PM CST

TSLA: 202.43 (+2.87), ITRI: 36.63 (-0.03), PNRA: 161.52 (-1.26), SKX: 68.43 (-0.02), STMP: 58.68 (+0.63), ZEN: 23.06 (+0.47), SLF: 31.13 (+0.37), FET: 19.71 (+0.34), HOS: 20.73 (-0.20), HIVE: 4.51 (-0.11), AEM: 30.78 (-0.87), CAKE: 48.08 (-0.63), AMAT: 24.27 (-0.22), CSCO: 29.33 (-0.21), WFM: 55.34 (-0.19), CJES: 13.32 (-0.16), HNI: 50.45 (-0.59), IO: 2.26 (+0.01), GAS: 47.94 (-0.26), QDEL: 25.95 (+0.14), CSOD: 31.64 (-0.62), EXL: 13.70 (-0.09), NVDA: 22.43 (+0.25), DDR: 18.79 (-0.20), NTWK: 6.19 (unch), AMBR: 8.81 (+0.10), CPA: 110.40 (-3.65), FORR: 37.57 (-0.39), AUY: 4.12 (-0.04), CTL: 36.25 (-1.43), ACHC: 65.59 (+0.20), OII: 53.90 (+0.08), NU: 52.54 (+1.31), CVA: 21.54 (-0.13), PPC: 28.03 (-0.58), REG: 65.28 (-0.69), TAL: 41.26 (-0.64), SWM: 46.26 (-0.10), Z: 112.96 (+1.29), FEYE: 43.82 (-1.25), ABCO: 53.72 (-0.16), TCX: 18.93 (+0.05), DIOD: 28.36 (+0.22), MET: 51.41 (-0.45), SPRT: 1.69 (-0.01), TRIP: 89.24 (-1.23), CYS: 9.08 (+0.03), NSIT: 26.83 (-0.37), TTGT: 11.98 (+0.06), NTAP: 37.80 (-0.23), EFX: 93.96 (-0.71), CRAY: 29.83 (-0.21), LPSN: 11.39 (-0.06), BIDU: 207.69 (+1.35), TSO: 89.70 (-1.34), CXW: 39.96 (-0.32), SCSS: 32.10 (+0.10), EFC: 20.20 (+0.04)

What's in Store for Acadia Healthcare (ACHC) this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 11:50AM CST
Acadia Healthcare Company, Inc. (ACHC) is set to report its fourth-quarter and full year 2014 earnings results on Feb 11
BLUE: 100.05 (+1.12), ACHC: 65.59 (+0.20), ACT: 296.14 (-0.09), ALNY: 107.23 (+0.32)

Acadia Healthcare Prices $375 Million Senior Unsecured Notes
Business Wire - Thu Feb 05, 3:00PM CST
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the pricing of $375 million in senior unsecured notes due 2023 (the "Notes" , which represents an upsizing of $75 million. The Notes will be sold to investors at a price of 100% of the principal amount thereof and will bear interest at a rate equal to 5.625% per annum.
ACHC: 65.59 (+0.20)

Acadia Healthcare Announces Proposed $300 Million Senior Unsecured Debt Offering
Business Wire - Wed Feb 04, 6:42AM CST
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it is proposing to issue $300 million in senior unsecured notes due 2023 (the "Notes" in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act" .
ACHC: 65.59 (+0.20)

Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2014 Earnings Release
Business Wire - Fri Jan 30, 10:00AM CST
Acadia Healthcare Company, Inc. ("Acadia" or the "Company" (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2014 earnings on Wednesday, February 11, 2015, after the market closes. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, February 12, 2015. Additionally, a live broadcast of the earnings conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available through February 27, 2015.
ACHC: 65.59 (+0.20)

Community Health Systems Divests Carolina Medical Center - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 05, 3:52PM CST
Community Health Systems (CYH) recently announced that subsidiaries of the company have successfully sold their ownership interest in Carolina Pines Regional Medical Center.
ACHC: 65.59 (+0.20), HCA: 74.93 (+4.14), CYH: 52.72 (+3.13), ADPT: 43.71 (-0.09)

11 Best Mid-Cap Health Care Stocks Worth Targeting for 2015
at The Street - Fri Jan 02, 1:43PM CST
Which mid-cap health care companies should you target for the best returns? Click through to see which stocks are top-rated.
ACHC: 65.59 (+0.20), SIRO: 91.56 (+0.34), WST: 54.52 (-0.19), USPH: 42.90 (+0.82), ATRI: 322.43 (-2.57), STE: 63.29 (-0.13), GB: 54.39 (+0.22), TFX: 121.17 (-1.24), ICLR: 67.72 (-0.34), CMN: 45.11 (-0.48), UTMD: 60.77 (+0.93)

Uptrend Call Working As Acadia Healthcare Stock Rises 42.4% (ACHC)
Comtex SmarTrend(R) - Tue Dec 30, 11:10AM CST
SmarTrend identified an Uptrend for Acadia Healthcare (NASDAQ:ACHC) on May 5th, 2014 at $44.05. In approximately 8 months, Acadia Healthcare has returned 42.36% as of today's recent price of $62.71.
ACHC: 65.59 (+0.20)

Actions Semiconductor's (ACTS) CEO Zhenyu Zhou on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 03, 1:07PM CST

ACTS: 1.63 (+0.03)

Actions Semiconductor EPS of -$0.20
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 6:35AM CST

ACTS: 1.63 (+0.03)

Actions Semiconductor Reports Fourth Quarter and Full Year 2014 Results
PR Newswire - Tue Feb 03, 6:30AM CST
Actions Semiconductor Co., Ltd. (Nasdaq: ACTS) ("Actions Semiconductor" or "the Company" , one of China's leading fabless semiconductor companies that provides comprehensive portable multimedia and mobile internet system-on-a-chip (SoC) solutions for portable consumer electronics, today reported its financial results for the fourth quarter and year ended December 31, 2014.
ACTS: 1.63 (+0.03)

Actions Semiconductor to Report Fourth Quarter and Fiscal Year 2014 Financial Results on February 3, 2015
PR Newswire - Tue Jan 20, 6:30AM CST
Actions Semiconductor Co., Ltd. (ACTS) ("Actions Semiconductor" or the "Company" , one of China's leading fabless semiconductor companies that provides comprehensive portable multimedia and mobile internet system-on-a-chip (SoC) solutions for portable consumer electronics, today announced it will release financial results for the fourth quarter and the fiscal year ended December 31, 2014, before the market opens on Tuesday, February 3, 2015. The Company will host a corresponding conference call and live webcast at 8:00 a.m. Eastern Standard Time on that day.
ACTS: 1.63 (+0.03)

Actions Launches Single-Chip Bluetooth 4.0 Multimedia Solution
PR Newswire - Tue Jan 06, 6:30AM CST
Actions Semiconductor Co., Ltd. (Nasdaq: ACTS) ("Actions Semiconductor" or "the Company" , one of China's leading fabless semiconductor companies that provides comprehensive portable multimedia and mobile internet system-on-a-chip (SoC) solutions for portable consumer electronics, today announced the launch of its new chipset, the ATS282X, an RF and audio processing integrated single-chip SoC for mid- to high-end Bluetooth stereo speakers, boomboxes and headphones.
ACTS: 1.63 (+0.03)

Actions to Debut First 64-bit Chipset at the 2015 International CES
PR Newswire - Mon Jan 05, 6:30AM CST
Actions Semiconductor Co., Ltd. (Nasdaq: ACTS) ("Actions Semiconductor" or "the Company" , one of China's leading fabless semiconductor companies that provides comprehensive portable multimedia and mobile internet system-on-a-chip (SoC) solutions for portable consumer electronics, today announced that it will debut the inaugural chipset of its new Falcon Series product family, the ATM9009, a 64-bit quad-core solution for high-end Android tablets and OTT set-top boxes at the 2015 International CES from January 6-9, in Las Vegas, Nevada.
ACTS: 1.63 (+0.03)

Accretive Capital Partners Nominates Richard Fearon And Dilip Singh To The Board Of Directors Of Actions Semiconductor
Richard E. Fearon, Jr. - Seeking Alpha - Wed Dec 31, 7:00AM CST
An Open Letter to the Board of Directors of Actions Semiconductor Co., Ltd. December 31, 2014 Mr. Hsiang-Wei Lee Chairman of the Board Actions Semiconductor Co., Ltd. Dear David: I received the December 19, 2014 email from your investor...
ACTS: 1.63 (+0.03)

Actions to Showcase Tablet and Bluetooth Boombox Solutions at the 2015 International CES
PR Newswire - Mon Dec 15, 7:00AM CST
Actions Semiconductor Co., Ltd. (Nasdaq: ACTS) ("Actions Semiconductor" or "the Company" , one of China's leading fabless semiconductor companies that provides comprehensive portable multimedia and mobile internet system-on-a-chip (SoC) solutions for portable consumer electronics, today announced it will showcase its latest tablet and Bluetooth boombox solutions and preview its upcoming products at the 2015 International CES. Owned and produced by the Consumer Electronics Association (CEA)®, the 2015 International CES, the world's gathering place for all who thrive on the business of consumer technologies, will run January 6-9, 2015 in Las Vegas, Nevada.
ACTS: 1.63 (+0.03)

Week In Review - Dec 5, 2014
China Stock Research - at Seeking Alpha - Mon Dec 08, 1:43PM CST
It was a tough week for U.S.-listed China stocks, with the majority of names ending lower by Friday. The PowerShares Golden Dragon China ETF (NYSEARCA: PGJ ), which tracks U.S.-listed Chinese companies, fell about 5% for the week, which put it back...
QIHU: 46.13 (-1.01), SOL: 1.43 (+0.08), NOAH: 20.83 (-0.01), ACTS: 1.63 (+0.03), JRJC: 6.23 (-0.10), GOMO: 4.84 (+0.02), YY: 51.44 (-1.29), DSKY: 11.82 (+0.55), ATHM: 42.61 (+4.21), TOUR: 14.87 (-0.20), PME: 2.58 (+0.03)

Accretive Capital Partners To Nominate 2 Directors To The Actions Semiconductor Board; Reiterates Demand For Additional Steps Followed By Immediate Sale Of Company
Richard E. Fearon, Jr. - Seeking Alpha - Thu Dec 04, 7:30AM CST
An Open Letter to the Board of Directors of Actions Semiconductor Co., Ltd. (NASDAQ: ACTS ) December 3, 2014 Mr. Hsiang-Wei Lee Chairman of the Board Actions Semiconductor Co., Ltd. Dear David: Thank you for your call last night. I...
ACTS: 1.63 (+0.03)

Actions Semiconductor EPS of $0.137
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 6:21AM CST

ACTS: 1.63 (+0.03)

Actions Semiconductor Reports Third Quarter 2014 Results
PR Newswire - Tue Nov 04, 6:00AM CST
Actions Semiconductor Co., Ltd. (Nasdaq: ACTS) ("Actions Semiconductor" or "the Company" , one of China's leading fabless semiconductor companies that provides comprehensive portable multimedia and mobile internet system-on-a-chip (SoC) solutions for portable consumer electronics, today reported its financial results for the third quarter ended September 30, 2014.
ACTS: 1.63 (+0.03)

Actions Semiconductor Debuts 28nm Quad-Core Processor for Mainstream Android Tablets
PR Newswire - Mon Nov 03, 6:55AM CST
Actions Semiconductor® Co., Ltd. (Nasdaq: ACTS) today introduced a new quad-core system-on-a-chip (SoC) to provide primary processing, connectivity, enhanced battery life and other capabilities in computer tablets and set top boxes (STB). The new processor is most ideal for mid-tier, high volume Android® tablet manufacturer designs. It will be available in the USA, Asia, Europe and other locations in November 2014.
ACTS: 1.63 (+0.03)

Actions Semiconductor to Report Third Quarter 2014 Financial Results on November 4, 2014
PR Newswire - Thu Oct 23, 7:00AM CDT
Actions Semiconductor Co., Ltd. (ACTS) ("Actions Semiconductor" or the "Company" , one of China's leading fabless semiconductor companies that provides comprehensive portable multimedia and mobile internet system-on-a-chip (SoC) solutions for portable consumer electronics, today announced it will release financial results for the third quarter ended September 30, 2014, before the market opens on Tuesday, November 4, 2014. The Company will host a corresponding conference call and live webcast at 8:00 a.m. Eastern Daylight Time on that day.
ACTS: 1.63 (+0.03)

Actions Semiconductor Debuts Its First 28nm OWL Series Chipset
PR Newswire - Tue Oct 21, 7:00AM CDT
Actions Semiconductor® Co., Ltd. (Nasdaq: ACTS), one of China's leading fabless semiconductor companies that provides comprehensive portable multimedia and mobile internet system-on-a-chip (SoC) solutions for portable consumer electronics, today announced that it debuted its latest innovative 28nm process based quad-core application processor offering for the tablet and OTT set-top box markets at Global Sources' China Sourcing Fair - Electronics & Components held October 11 - 14 at the Asia World-Expo in Hong Kong.
ACTS: 1.63 (+0.03)

Accretive Capital Partners Commends Actions Semiconductor for Dutch Auction Tender Offer; Demands Additional Steps Followed by Immediate Sale of Company
ACCESSWIRE - Fri Oct 17, 11:19AM CDT
An Open Letter to the Board of Directors of Actions Semiconductor Co., Ltd.
ACTS: 1.63 (+0.03)

Accretive Capital Partners Sends Open Letter to Board of Directors of Actions Semiconductor Co., Ltd.
ACCESSWIRE - Fri Oct 17, 7:46AM CDT
Commends Board for Dutch Auction Tender Offer; Demands Additional Steps and Eventual Sale of Company
ACTS: 1.63 (+0.03)

Aerocentury beats by $0.90, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 8:35AM CST

ACY: 12.78 (+1.69)

AeroCentury Corp. Reports Profitable Fourth Quarter 2014
PR Newswire - Tue Mar 03, 8:00AM CST
AeroCentury Corp. (NYSE MKT: ACY), an independent aircraft leasing company, today reported its unaudited operating results for the fourth quarter and year ended December 31, 2014.
ACY: 12.78 (+1.69)

AeroCentury Down 47.5% Since SmarTrend Downtrend Call (ACY)
Comtex SmarTrend(R) - Fri Feb 13, 9:10AM CST
SmarTrend identified a Downtrend for AeroCentury (AMEX:ACY) on May 13th, 2014 at $15.80. In approximately 9 months, AeroCentury has returned 47.53% as of today's recent price of $8.29.
ACY: 12.78 (+1.69)

AeroCentury Corp. Announces Addition To Board Of Directors
PR Newswire - Mon Feb 09, 11:00AM CST
AeroCentury Corp. (NYSE MKT: ACY), an independent aircraft leasing company, today announced the addition of David P. Wilson to its Board of Directors.
ACY: 12.78 (+1.69)

Shares of ACY Down 47.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 05, 4:37PM CST
SmarTrend identified a Downtrend for AeroCentury (AMEX:ACY) on May 13th, 2014 at $15.80. In approximately 9 months, AeroCentury has returned 47.79% as of today's recent price of $8.25.
ACY: 12.78 (+1.69)

Rent-A-Center Crashes on Q4 Earnings and Revenue Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 8:35AM CST
Shares of Rent-A-Center (RCII) nosedived 14.1% during after-market trading hours yesterday following the disappointing fourth-quarter 2014 performance of this rent-to-own operator.
AER: 44.78 (+0.34), RCII: 27.19 (-0.12), MGRC: 31.17 (-1.05), ACY: 12.78 (+1.69)

50.0% Return Seen to Date on SmarTrend AeroCentury Call (ACY)
Comtex SmarTrend(R) - Thu Jan 29, 10:58AM CST
SmarTrend identified a Downtrend for AeroCentury (AMEX:ACY) on May 13th, 2014 at $15.80. In approximately 9 months, AeroCentury has returned 50.00% as of today's recent price of $7.90.
ACY: 12.78 (+1.69)

Shares of ACY Down 50.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 22, 9:37AM CST
SmarTrend identified a Downtrend for AeroCentury (AMEX:ACY) on May 13th, 2014 at $15.80. In approximately 8 months, AeroCentury has returned 50.51% as of today's recent price of $7.82.
ACY: 12.78 (+1.69)

AeroCentury Has Returned 47.5% Since SmarTrend Recommendation (ACY)
Comtex SmarTrend(R) - Wed Jan 07, 4:44PM CST
SmarTrend identified a Downtrend for AeroCentury (AMEX:ACY) on May 13th, 2014 at $15.80. In approximately 8 months, AeroCentury has returned 47.47% as of today's recent price of $8.30.
ACY: 12.78 (+1.69)

AeroCentury Shares Down 46.2% Since SmarTrend's Sell Call (ACY)
Comtex SmarTrend(R) - Wed Dec 31, 11:11AM CST
SmarTrend identified a Downtrend for AeroCentury (AMEX:ACY) on May 13th, 2014 at $15.80. In approximately 8 months, AeroCentury has returned 46.20% as of today's recent price of $8.50.
ACY: 12.78 (+1.69)

Downtrend Call Working As AeroCentury Stock Falls 45.9% (ACY)
Comtex SmarTrend(R) - Wed Dec 24, 9:36AM CST
SmarTrend identified a Downtrend for AeroCentury (AMEX:ACY) on May 13th, 2014 at $15.80. In approximately 8 months, AeroCentury has returned 45.89% as of today's recent price of $8.55.
ACY: 12.78 (+1.69)

45.7% Return Seen to Date on SmarTrend AeroCentury Call (ACY)
Comtex SmarTrend(R) - Wed Dec 17, 9:08AM CST
SmarTrend identified a Downtrend for AeroCentury (AMEX:ACY) on May 13th, 2014 at $15.80. In approximately 7 months, AeroCentury has returned 45.70% as of today's recent price of $8.58.
ACY: 12.78 (+1.69)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 11:46AM CST

ZIOP: 13.34 (+0.85), BSPM: 1.18 (-0.04), BDR: 1.80 (+0.07), ZAZA: 2.09 (-0.07), ACY: 12.78 (+1.69), NBS: 4.03 (+0.04), SYRX: 1.36 (-0.02), IAG: 2.24 (-0.09), THTI: 1.09 (unch), BITA: 68.24 (+2.83), VRTB: 3.31 (-0.03), OPTT: 0.54 (-0.01), INVT: 0.51 (+0.01), GERN: 2.81 (-0.15), VASC: 29.24 (+0.05), LOCM: 0.67 (+0.02), CTHR: 1.50 (+0.06), MOV: 24.64 (-0.80), IFON: 2.71 (+1.01), SVM: 1.27 (-0.04)

Aerocentury EPS of -$5.34
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 5:06PM CST

ACY: 12.78 (+1.69)

AeroCentury Corp. Reports Third Quarter 2014 Results
PR Newswire - Thu Nov 13, 5:00PM CST
AeroCentury Corp. (NYSE MKT: ACY), an independent aircraft leasing company, today reported its operating results for the third quarter ended September 30, 2014. Effective as of January 1, 2014, the Company adopted an alternate method of accounting for non-refundable maintenance reserves and certain lessor maintenance costs. In order to provide a meaningful comparison for third quarter 2014 results, the September 30, 2013 and December 31, 2013 results stated below and in the accompanying tables were calculated as if the new method of accounting were in effect throughout the applicable periods ending on those dates.
ACY: 12.78 (+1.69)

Adamis Pharmaceuticals Announces Positive Pharmacokinetic Study Results For Its Dry Powder Inhaler Product
GlobeNewswire - Tue Mar 03, 8:00AM CST
Adamis Pharmaceuticals Corporation (Nasdaq:ADMP) ("Company" today announced the results of its pharmacokinetic (PK) study for its dry powder inhaler product, APC-5000. The study was a Phase I PK study comparing the bioavailability of Adamis' APC-5000 Dry Powder Inhaler (DPI) to GlaxoSmithKline's Advair(R) Diskus(R) DPI.
ADMP: 7.07 (+0.25), GSK: 47.82 (+0.11)

Vaccine Partnering Terms and Agreements Report 2014 (Updated Edition)
M2 - Tue Feb 17, 2:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/rk95vj/vaccine) has announced the addition of the "Vaccine Partnering Terms and Agreements" report to their offering. The report provides a detailed understanding and analysis of how and why companies enter vaccine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report also includes adjuvant deals and alliances. The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. - Trends in vaccine and adjuvant partnering deals - Deal terms analysis - Partnering agreement structure - Partnering contract documents - Top deals by value - Most active dealmakers - Average deal terms for vaccines Key Topics Covered: Executive Summary Chapter 1 - Introduction Chapter 2 - Trends in vaccine dealmaking Chapter 3 - Leading vaccine deals Chapter 4 - Big pharma vaccine deals Chapter 5 - Big biotech vaccine deals Chapter 6 - Vaccine contracts dealmaking directory Chapter 7 - Vaccine dealmaking directory by technology type Chapter 8 - Vaccine partnering resource center Companies Mentioned - 30 of the 100 Companies Listed - Abbott - Achaogen - Adamis Pharmaceuticals - Advaxis - Agenus Bio - Antigenics - Argos Therapeutics - Astellas - AstraZeneca - Avecia Biologics - AVI Pharma - Avimex - Bavarian Nordic - Baxter International - Bayer - BioCryst Pharmaceuticals - Biogen Idec - Bio-Matrix Scientific - Biomedical Advanced Research and Development Authority - Boehringer Ingelheim - Bristol-Myers Squibb - Cadila Pharmaceuticals - Cangene - Cedars-Sinai Medical Center - CPL Biologicals - Crucell - CSL - Daiichi Sankyo - Dainippon Sumitomo - Dana-Farber Cancer Institute For more information visit http://www.researchandmarkets.com/research/rk95vj/vaccine
BIIB: 414.13 (+1.34), ARGS: 9.14 (+0.06), BCRX: 10.49 (+0.43), BAX: 69.25 (-0.17), ADMP: 7.07 (+0.25), BMY: 65.67 (+3.75)

Adamis Pharmaceuticals Receives Notice of Allowance for US and Japanese Patents for Its Dry Powder Inhaler
GlobeNewswire - Wed Jan 28, 9:28AM CST
Adamis Pharmaceuticals Corporation (Nasdaq:ADMP) ("Company" recently received a notice of allowance that one of its patent applications for its proprietary dry powder inhaler, Taper DPI, will issue in the United States (U.S. Patent Application No. 13/320,762) and in Japan (Japanese Patent Application No. 2012-511965). The approved claims describe the device and components that are important for its function.
ADMP: 7.07 (+0.25)

Adamis Pharmaceuticals: A Specialty Pharma Ready For The Next Level
James W. Burke - Seeking Alpha - Wed Jan 21, 9:54AM CST
It was just over a year ago that I wrote an article on a small, relatively unknown company, Adamis Pharmaceuticals (NASDAQ: ADMP ). In the article, I explained how Adamis was really two great companies for the price of one: the Specialty...
SLXP: 157.13 (+0.63), ADMP: 7.07 (+0.25), MYL: 55.60 (+0.16)

Global Prostate Cancer Vaccine Clinical Pipeline Insight 2015
M2 - Wed Jan 21, 5:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/qxt9lq/global_prostate) has announced the addition of the "Global Prostate Cancer Vaccine Clinical Pipeline Insight 2015" report to their offering. Prostate cancer vaccine is a recent development which is more potent than presently available prostate cancer therapeutics in providing better medical care. Prophylactic nature of this vaccine makes it possible to prevent the future incidences of prostate cancer. Besides, it can also prevent the relapse, provides long- term immunity, decrease morbidity and mortality rates along with increasing longevity. Owing to these benefits offered by prostate cancer vaccines their acceptance is increasing among patients and physicians in recent years. It is expected that due competition and increased number of products in market will cause decrease in the price of prostate cancer vaccines in coming years. Prostate cancer vaccine utilizes different antigens like Prostate-Specific Membrane Antigen, Prostate-Specific Antigen (PSA) and Prostatic Acid Phosphatase (PAP) in pharmacological formulations. These antigens are isolated from the prostate tumor and injected into the body to activate the immune cells. They identify these antigens as non-self and begin to search and eliminate cancerous cells from body to prevent proliferation of cancerous cells. Highly specific nature causes elimination of cancerous cells in prostate while sparing normal cells leading to minimized side effects in patients. Global Prostate Cancer Vaccine Clinical Pipeline Insight 2015 Report Highlights: - Introduction to Prostate Cancer Vaccine - Mechanism of Prostate Cancer Vaccine - Global Prostate Cancer Vaccine Clinical Trial Insight by Company, Country & Phase - Global Prostate Cancer Vaccine Clinical Pipeline: 41 Vaccines - Majority Prostate Cancer Vaccine in Phase-II: 10 Vaccines - Marketed Prostate Cancer Vaccine: 1 (Provenge by Dendreon Corporation) Key Topics Covered: 1. Introduction to Prostate Cancer Vaccine 2. Mechanism of Prostate Cancer Vaccine 3. Global Prostate Cancer Vaccine Market Dynamics 4. Global Prostate Cancer Vaccine Market Outlook 5. Global Prostate Cancer Vaccine Market Future Prospects 6. Personalized Cancer Vaccine Market Opportunities 7. Global Prostate Cancer Vaccines Clinical Trial Insight by Company, Country & Phase 8. Marketed Prostate Cancer Vaccines by Company & Country 9. Suspended & Discontinued Prostate Cancer Vaccines in Clinical Trials 10. Competitive Landscape - Adamis Pharmaceuticals - Aduro BioTech - Bellicum Pharmaceuticals - CytoVac - Dendreon Corporation - Generex Biotechnology Corporation - Immunovaccine - Oncbiomune - Progenics - Sotio For more information visit http://www.researchandmarkets.com/research/qx...l_prostate
BLCM: 24.32 (+0.92), ADMP: 7.07 (+0.25)

Adamis Pharmaceuticals concludes public offering at USD5.00 per share
M2 - Thu Jan 15, 5:08AM CST
Biopharmaceutical company Adamis Pharmaceuticals (NasdaqCM:ADMP) said on Wednesday that it has completed its public offering of 2,000,000 shares of common stock at USD5.00 per share.
ADMP: 7.07 (+0.25)

Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full
GlobeNewswire - Wed Jan 14, 9:20AM CST
Adamis Pharmaceuticals Corporation (Nasdaq:ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease, allergy, oncology and immunology, announced today the closing of its previously announced underwritten public offering of 2,000,000 shares of common stock at a public offering price of $5.00 per share, as well as 300,000 additional shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriters.
ADMP: 7.07 (+0.25)

Direction of Market Influences: New Coverage of Acorda, Acura Pharmaceuticals, Adamas, Adamis and Addus HomeCare
PR Newswire - Wed Jan 14, 6:30AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Acorda (NASDAQ: ACOR), Acura Pharmaceuticals (NASDAQ: ACUR), Adamas (NASDAQ: ADMS), Adamis (NASDAQ: ADMP), and Addus HomeCare (NASDAQ: ADUS). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
ADMS: 17.36 (+0.11), ADUS: 22.17 (+0.03), ADMP: 7.07 (+0.25), ACOR: 35.74 (+0.54), ACUR: 0.74 (-0.08)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 11:47AM CST

EOPN: 8.56 (unch), ADHD: 7.41 (+0.21), CNAT: 6.30 (-0.02), ADMP: 7.07 (+0.25), FIVE: 30.96 (-0.45), TESO: 10.78 (+0.21), ALXA: 2.07 (+0.01), PRTO: 10.59 (+0.21), AGEN: 5.09 (+0.24), ARGS: 9.14 (+0.06), TOPS: 1.05 (+0.01), HILL: 4.31 (+0.14), EDAP: 4.02 (+0.09), CTSO: 10.87 (-0.06), VLCCF: 4.98 (-0.12), SCYX: 9.27 (-0.63), VIMC: 10.13 (+0.17), SBLK: 4.11 (-0.06), DCTH: 1.20 (-0.03), IDN: 1.43 (unch)

Adamis plummets after pricing offering at a discount
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 9:32AM CST

ADMP: 7.07 (+0.25)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 8:10AM CST

SD: 1.74 (unch), PTLA: 42.88 (+1.68), EOPN: 8.56 (unch), CNAT: 6.30 (-0.02), ADMP: 7.07 (+0.25), INFY: 36.12 (-0.76), FIVE: 30.96 (-0.45), AGEN: 5.09 (+0.24), SAN: 7.20 (-0.03), EDAP: 4.02 (+0.09), GMLP: 26.02 (+0.02), CTSO: 10.87 (-0.06), SBLK: 4.11 (-0.06), IDN: 1.43 (unch)

Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
GlobeNewswire - Fri Jan 09, 8:04AM CST
Adamis Pharmaceuticals Corporation (Nasdaq:ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease, allergy, oncology and immunology, announced today the pricing of its previously announced underwritten public offering of 2,000,000 shares of common stock at a public offering price of $5.00 per share, resulting in gross proceeds of approximately $10,000,000.
ADMP: 7.07 (+0.25)

Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
GlobeNewswire - Thu Jan 08, 3:36PM CST
Adamis Pharmaceuticals Corporation (Nasdaq:ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease, allergy, oncology and immunology, announced today that it intends to offer shares of its common stock in an underwritten public offering. The company expects to grant the underwriters of the offering an option to purchase additional shares of common stock to cover over-allotments, if any. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
ADMP: 7.07 (+0.25)

Adamis Pharmaceuticals to Present at Two Upcoming Conferences
GlobeNewswire - Tue Dec 02, 8:01AM CST
Adamis Pharmaceuticals Corporation (Nasdaq:ADMP) today announced that the Company is scheduled to present a company overview at two upcoming conferences.
ADMP: 7.07 (+0.25)

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2014
M2 - Tue Dec 02, 6:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/53cpct/chronic) has announced the addition of the "Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and special features on late-stage and discontinued projects. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Chronic Obstructive Pulmonary Disease (COPD) - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Chronic Obstructive Pulmonary Disease (COPD) pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Companies Mentioned: 100 companies are cited in this text including: - Ache Laboratorios Farmaceuticos S/A - Adamis Pharmaceuticals Corporation - Advinus Therapeutics Ltd. - AIM Therapeutics Inc. - Axikin Pharmaceuticals, Inc. - Basilea Pharmaceutica AG - Daiichi Sankyo Company, Limited - Errant Gene Therapeutics, LLC - Five Prime Therapeutics, Inc. - GlaxoSmithKline plc - Hydra Biosciences, Inc. - iCeutica, Inc. - Johnson & Johnson - KaloBios Pharmaceuticals, Inc. - Medestea Research & Production S.p.A. - Novartis AG - Ockham Biotech Limited - Pfizer Inc. - PharmaLundensis - Re-Pharm - Seoul Pharma - Takeda Pharmaceutical Company - Zambon Company For more information visit http://www.researchandmarkets.com/research/53cpct/chronic
JNJ: 101.65 (-0.69), KBIO: 0.75 (+0.05), PFE: 34.64 (+0.08), ADMP: 7.07 (+0.25), GSK: 47.82 (+0.11), NVS: 99.04 (-0.02), FPRX: 25.08 (+0.32)

Contraception - Pipeline Review, H2 2014
M2 - Mon Dec 01, 3:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/rzn2sh/contraception) has announced the addition of the "Contraception - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Contraception, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Contraception and special features on late-stage and discontinued projects. This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Contraception - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Contraception pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Companies Mentioned: - Actavis - Adamis Pharmaceuticals - Agile - ANI - Antares - Bayer - Evofem - HRA Pharma - Hydra Biosciences - Intas - Ligand - Merck & Co - Orbis Biosciences - Pantarhei Bioscience - Teva Pharmaceutical Industries For more information visit http://www.researchandmarkets.com/research/rz...traception
MRK: 57.88 (-0.46), ADMP: 7.07 (+0.25), TEVA: 56.56 (+0.10)

Global Herpes Simplex Infections Therapeutics Pipeline Report H2 2014 - Analysis of 31 Companies & 46 Drug Profiles
M2 - Mon Nov 10, 10:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/lk8z5n/herpes_simplex) has announced the addition of the "Herpes Simplex Infections - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Herpes Simplex Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Herpes Simplex Infections and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Sanofi - GenVec, Inc. - Astellas Pharma Inc. - CEL-SCI Corporation - Mymetics Corporation - NovaBay Pharmaceuticals, Inc. - Peregrine Pharmaceuticals, Inc. - Oryzon Genomics S.A. - Colby Pharmaceutical Company - ViroStatics, srl - Osel Inc. - AlphaVax, Inc. - Romark Laboratories, L.C. - Chimerix, Inc. - NanoBio Corporation - Immunovaccine, Inc. - Immune Design Corp. - Seek - Adamis Pharmaceuticals Corporation - Vaxart, Inc. - Genocea Biosciences, Inc. - Pharis Biotec GmbH - Profectus BioSciences, Inc. - 3-V Biosciences, Inc. - PaxVax - Spider Biotech - Kala Pharmaceuticals, Inc. - Vaccibody AS - Sanofi Pasteur SA - Humabs BioMed SA Drug Profiles - amenamevir - GEN-003 - herpes simplex virus vaccine - HSV-529 - brincidofovir - CEL-1000 - Vaccine for Herpes Simplex Infections - herpes simplex vaccine [HSV-2] - C-31G - Cyanovirin-N for Infectious Disease - GEN-002 - NVC-727 - NVC-638 - NVC-704 - JVRS-100 Herpes Simplex Virus-2 Vaccine - Drug for Herpes Simplex - PGN-632 - G-103 - GV-2207 - acyclovir - SB-105 - Monoclonal Antibodies for HIV and Herpes Simplex Infections - Synthetic Peptide for Oncology and Infectious Disease - herpes simplex virus vaccine - MB-66 - Small Molecule to Inhibit Fatty Acid Synthase for Viral Infections - BA-368 - HSV-2 Vaccine - Small Molecule Inhibiting Kinases for Viral Infections - mab hu2c For more information visit http://www.researchandmarkets.com/research/lk...es_simplex
IMDZ: 23.55 (+0.68), CMRX: 40.74 (+0.25), CVM: 1.19 (+0.05), ADMP: 7.07 (+0.25), GNCA: 8.33 (-0.02)

Adamis Pharmaceuticals Announces Key Additions to Medical and Commercial Teams
GlobeNewswire - Wed Oct 15, 8:35AM CDT
Adamis Pharmaceuticals Corporation (Nasdaq:ADMP) today announced key additions to its medical and product marketing management teams. These new employees position the company for further development of its product pipeline and the preparation of a sales and marketing plan for the anticipated launch of its epinephrine pre-filled syringe for treatment of allergic reactions (Type I) including anaphylaxis.
ADMP: 7.07 (+0.25)

Market Maker Surveillance Report. IDN, VII, ISNS, DGLY, MGT, ADMP, Winning Stocks With Lowest Price Friction For Tuesday, September 2nd 2014
M2 - Thu Sep 04, 9:47AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4916 companies with "abnormal" market making, 2511 companies with positive Friction Factors and 2570 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Intellicheck Mobilisa Inc (NYSE:IDN), Vicon Industries Inc (NYSE:VII), Image Sensing Systems Inc (NASDAQ:ISNS), Digital Ally Inc (NASDAQ GLY), MGT Capital Investments Inc (NYSE:MGT), Adamis Pharmaceuticals Corp (NASDAQ:ADMP). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
MGT: 0.79 (+0.08), ADMP: 7.07 (+0.25), ISNS: 2.54 (+0.02), VII: 1.38 (-0.05), DGLY: 13.18 (-1.04), IDN: 1.43 (unch)

Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Marketwire - Tue Aug 26, 6:15AM CDT
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced the appointment of Richard C. Williams, Robert B. Rothermel and William C. Denby to its Board of Directors. Mr. Williams was also appointed as Chairman of the Board.
ADMP: 7.07 (+0.25)